Royalty Pharma (NASDAQ:RPRX) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Royalty Pharma missed estimated earnings by 10.26%, reporting an EPS of $0.7 versus an estimate of $0.78.
Revenue was down $19.05 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.13 which was followed by a 2.58% drop in the share price the next day.
Here’s a look at Royalty Pharma’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.73 | 0.77 | 0.69 | |
| EPS Actual | 0.60 | 0.80 | 0.24 | 0.73 |
| Revenue Estimate | 599.76M | 556.79M | 578.20M | 483.42M |
| Revenue Actual | 562.00M | 576.00M | 585.77M | 555.00M |
To track all earnings releases for Royalty Pharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
